Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

$ API Reference Price

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 Canada

1 FDF Dossiers
1 Canada

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 5,790

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Mls002702991, Nsc58368, Fumagillin, compd. with dicyclohexylamine (1:1), Fugillin dicyclohexylamine salt, Chembl2006353, Nsc-58368

Molecular Formula

C₃₈H₅₇NO₇

Molecular Weight

639.9 g/mol

InChI Key

OLRILZDTQKZQIG-GRJGWNIVSA-N

1 2D Structure

Fumagillin Dicyclohexylamine Salt

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-cyclohexylcyclohexanamine;(2E,4E,6E,8E)-10-[[5-methoxy-4-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl]oxy]-10-oxodeca-2,4,6,8-tetraenoic acid

2.1.2 InChI

InChI=1S/C26H34O7.C12H23N/c1-18(2)13-14-20-25(3,33-20)24-23(30-4)19(15-16-26(24)17-31-26)32-22(29)12-10-8-6-5-7-9-11-21(27)28;1-3-7-11(8-4-1)13-12-9-5-2-6-10-12/h5-13,19-20,23-24H,14-17H2,1-4H3,(H,27,28);11-13H,1-10H2/b7-5+,8-6+,11-9+,12-10+;

2.1.3 InChI Key

OLRILZDTQKZQIG-GRJGWNIVSA-N

2.1.4 Canonical SMILES

CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)C=CC=CC=CC=CC(=O)O)OC)C.C1CCC(CC1)NC2CCCCC2

2.1.5 Isomeric SMILES

CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)/C=C/C=C/C=C/C=C/C(=O)O)OC)C.C1CCC(CC1)NC2CCCCC2

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. Mls002702991

2. Nsc58368

3. Fumagillin, Compd. With Dicyclohexylamine (1:1)

4. Fugillin Dicyclohexylamine Salt

5. Chembl2006353

6. Nsc-58368

7. Akos032948019

8. Fumagillin, Compd. With Dicyclohexylamine

9. 2,6,8-decatetraenedioic Acid, 4-(1,2-epoxy-1,5-dimethyl-4-hexenyl)-5-methoxy-1-oxaspiro[2.5]oct-6-yl Ester, Compd. With Dicyclohexylamine (1:1)

2.3 Create Date

2005-03-26

3 Chemical and Physical Properties

Molecular Formula	C₃₈H₅₇NO₇
Molecular Weight	639.9 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	8
Rotatable Bond Count	13
Exact Mass	639.41350316 g/mol
Monoisotopic Mass	639.41350316 g/mol
Topological Polar Surface Area	110 Å²
Heavy Atom Count	46
Formal Charge	0
Complexity	995
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	6
Defined Bond Stereocenter Count	4
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2